Outcomes of Acitretin Treatment for Refractory Multikinase Inhibitor-Induced Hand-Foot Skin Reaction

JAMA Dermatol. 2022 Jul 1;158(7):824-826. doi: 10.1001/jamadermatol.2022.1425.

Abstract

This cohort study assesses the outcomes of acitretin treatment for multikinase inhibitor–associated hand-foot skin reaction.

MeSH terms

  • Acitretin* / adverse effects
  • Hand-Foot Syndrome* / diagnosis
  • Hand-Foot Syndrome* / etiology
  • Humans
  • Skin
  • Sorafenib

Substances

  • Sorafenib
  • Acitretin